Filtered By:
Procedure: Percutaneous Coronary Intervention

This page shows you your search results in order of date. This is page number 18.

Order by Relevance | Date

Total 3177 results found since Jan 2013.

Lower Baseline LDL Cholesterol Affects All-cause Mortality in Patients with First Percutaneous Coronary Intervention
CONCLUSION: In this study, a high baseline LDL-C was not associated with a low risk of clinical outcomes in CAD patients undergoing first PCI, which suggested that the "cholesterol paradox" may be inapplicable to Chinese populations.PMID:37105907 | DOI:10.3967/bes2023.038
Source: Biomedical and Environmental Sciences : BES - April 27, 2023 Category: Biomedical Science Authors: Xi Chen Hao Chen Bo Lu Wei Min Zhang Yuan Tao Qing Cheng Wang Guo Sheng Fu Wen Bin Zhang Source Type: research

Safety and Efficacy of Ticagrelor versus Clopidogrel in East Asian Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Treated with Dual Antiplatelet Therapy: A Meta-Analysis of Randomized Controlled Trials
Conclusion: Ticagrelor increased the risk of bleeding and did not increase treatment efficacy compared to that of clopidogrel in the East Asian population who have ACS treated with PCI.
Source: Cardiology - April 24, 2023 Category: Cardiology Source Type: research

Influence of an abnormal ankle-brachial index on ischemic and bleeding events in patients undergoing percutaneous coronary intervention
CONCLUSIONS: An abnormal ABI is a risk factor for both ischemic and bleeding events after PCI. Our study findings may be helpful in determining the optimal method for secondary prevention after PCI.PMID:37077131 | DOI:10.3904/kjim.2022.348
Source: The Korean Journal of Internal Medicine - April 20, 2023 Category: Internal Medicine Authors: Hangyul Kim Seung Do Lee Hyo Jin Lee Hye Ree Kim Kyehwan Kim Jin-Sin Koh Seok-Jae Hwang Jin-Yong Hwang Jong-Hwa Ahn Yongwhi Park Young-Hoon Jeong Jeong Rang Park Min Gyu Kang Source Type: research

Patients with higher-atherothrombotic risk vs. lower-atherothrombotic risk undergoing coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials
ConclusionIn the era of newer-generation DES, patients with H-ATR still are at hazard for ischemic events. Patients with BP-SES had lower TLF rates as compared with DP-EES, most consistent in L-ATR whereas in H-ATR patients most probably secondary preventive strategies are of higher value.Clinical trial registrationClinicaltrial.gov. NCT01356888, NCT01939249, NCT02389946.https://clinicaltrials.gov/show/NCT01356888,https://clinicaltrials.gov/show/NCT01939249,https://clinicaltrials.gov/show/NCT02389946.Graphical abstract
Source: Clinical Research in Cardiology - April 16, 2023 Category: Cardiology Source Type: research

Residual coronary artery tree description and lesion EvaluaTion (CatLet) score, clinical variables, and their associations with outcome predictions in patients with acute myocardial infarction
CONCLUSION: The rCatLet score has a predicting value for clinical outcomes for AMI patients and the incorporation of the three CVs into the rCatLet score will enhance its predicting ability.TRIAL REGISTRATION: http://www.chictr.org.cn, ChiCTR-POC-17013536.PMID:37052135 | DOI:10.1097/CM9.0000000000002640
Source: Chinese Medical Journal - April 13, 2023 Category: General Medicine Authors: Mingxing Xu Shu Wang Ying Zhang Jie Zhang Jin Ma Junfei Shen Yida Tang Tingbo Jiang Yongming He Source Type: research